1887

Abstract

A brain homogenate prepared from a terminally ill hamster infected with scrapie strain 263K was serially diluted and administered orally to groups of hamsters. The undiluted brain homogenate led to clinical scrapie in all animals inoculated. The attack rate decreased with dilutions of the homogenate, and subclinical infections were identified among the healthy survivors at 520 days post-infection by Western blotting. The number of animals succumbing to disease and the combined number of Western blot-positive survivors plus diseased hamsters were used to calculate the LD and ID of the inoculum. The model system represents an approximation to the transmission of TSEs such as new variant Creutzfeldt–Jakob disease (vCJD) via dietary exposure to the infectious agent and suggests that, due to the rather small difference between the calculated LD and ID, the number of clinical cases will not be vastly exceeded by the number of subclinical carriers of the disease.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19037-0
2003-07-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/7/vir841927.html?itemId=/content/journal/jgv/10.1099/vir.0.19037-0&mimeType=html&fmt=ahah

References

  1. Alperovitch A., Zerr I., Pocchiari M. 7 other authors 1999; Codon 129 prion protein genotype and sporadic Creutzfeldt–Jakob disease. Lancet 353:1673–1674
    [Google Scholar]
  2. d'Aignaux J. N., Cousens S. N., Smith P. G. 2001; Predictability of the UK variant Creutzfeldt–Jakob disease epidemic. Science 294:1729–1731
    [Google Scholar]
  3. Hill A. F., Joiner S., Linehan J., Desbruslais M., Lantos P. L., Collinge J. 2000; Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A 97:10248–10253
    [Google Scholar]
  4. Hilton D. A., Ghani A. C., Conyers L., Edwards P., McCardle L., Penney M., Ritchie D., Ironside J. W. 2002; Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br Med J 325:633–634
    [Google Scholar]
  5. Jackson G. S., Beck J. A., Navarrete C., Brown J., Sutton P. M., Contreras M., Collinge J. 2001; HLA-DQ7 antigen and resistance to variant CJD. Nature 414:269–270
    [Google Scholar]
  6. Lloyd S. E., Onwuazor O. N., Beck J. A., Mallinson G., Farrall M., Targonski P., Collinge J., Fisher E. M. 2001; Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A 98:6279–6283
    [Google Scholar]
  7. Manolakou K., Beaton J., McConnell I., Farquar C., Manson J., Hastie N. D., Bruce M., Jackson I. J. 2001; Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci U S A 98:7402–7407
    [Google Scholar]
  8. Race R., Raines A., Raymond G. J., Caughey B., Chesebro B. 2001; Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt–Jakob disease in humans. J Virol 75:10106–10112
    [Google Scholar]
  9. Race R., Meade-White K., Raines A., Raymond G. J., Caughey B., Chesebro B. 2002; Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186 (Suppl. 2):166–170
    [Google Scholar]
  10. Riemer C., Queck I., Simon D., Kurth R., Baier M. 2000; Identification of upregulated genes in scrapie-infected brain tissue. J Virol 74:10245–10248
    [Google Scholar]
  11. Spouge J. L. 1992; Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci U S A 89:7581–7585
    [Google Scholar]
  12. Stephenson D. A., Chiotti K., Ebeling C., Groth D., DeArmond S. J., Prusiner S. B., Carlson G. A. 2000; Quantitative trait loci affecting prion incubation time in mice. Genomics 69:47–53
    [Google Scholar]
  13. Thackray A. M., Klein M. A., Aguzzi A., Bujdoso R. 2002; Chronic subclinical prion disease induced by low-dose inoculum. J Virol 76:2510–2517
    [Google Scholar]
  14. Valleron A. J., Boelle P. Y., Will R., Cesbron J. Y. 2001; Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294:1726–1728
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19037-0
Loading
/content/journal/jgv/10.1099/vir.0.19037-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error